Redwood City, CA, United States of America

Jasna Brcic

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Leland Stanford Junior University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jasna Brcic. Retrieved from https://idiyas.com/inventor/jasna-brcic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jasna Brcic: Inventor of a Therapeutic Dendrimer Patent

Introduction

Jasna Brcic is an inventor associated with Redwood City, California, and Leland Stanford Junior University. Her patent work concerns therapeutic compounds designed to deliver molecular cargo to cells, including bacteria.

Latest Patents

Brcic is associated with 1 patent: “Composition and Method for New Therapeutic Agents Including Guanidinium-Presenting Dendrimers and Branched Structures.” The patent describes the design, synthesis, and biological evaluation of conjugate compounds incorporating dendrimeric moieties and branched structures. It also covers pharmaceutical compositions and methods for delivering cargo to cells.

The disclosed methods include applications targeting bacterial populations. In certain embodiments, the compounds are described as capable of reducing or eradicating Gram-positive bacteria, mycobacteria, Gram-negative bacteria, or bacterial biofilms. The patent also discusses using these conjugates to treat diseases or conditions, including infectious diseases.

Career Highlights

Brcic’s listed patent is connected to research at Leland Stanford Junior University. Its focus on dendrimer-based therapeutic agents reflects an effort to develop compounds with potential applications in antimicrobial treatment and cellular delivery.

Collaborations

The available information associates Brcic’s patent with Leland Stanford Junior University. It does not specify additional collaborators.

Conclusion

Jasna Brcic’s patent documents research into dendrimeric and branched therapeutic compounds, with proposed uses that include antimicrobial activity and treatment of infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…